BTIG analyst Marie Thibault reiterated a Neutral rating and {REMOVEPT} price target on Orchestra BioMed Inc. (NASDAQ: OBIO).The analyst commented ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments